For just pennies a day, chromium picolinate supplements can save the U.S. economy significantly in diabetes-related coronary heart disease healthcare costs.
Chromium picolinate has been found to help maintain healthy blood sugar and insulin levels as well as lower cholesterol and triglyceride levels. Elevated levels of these biomarkers are risk factors for diabetes and heart disease, so maintaining healthy levels is important.
A new economic report shows that taking specific dietary supplements can provide significant individual and societal healthcare savings by reducing the number of hospitalizations and other costly medical events associated with chronic diseases. This infographic demonstrates the cost savings that can be realized through the utilization of chromium picolinate dietary supplements among all U.S. adults over the age of 55 with diabetes-attributed coronary heart disease (CHD).
Click image above to view larger (or download original)
Courtesy of the Council for Responsible Nutrition Foundation (CRNF; Washington, DC), sourced from Frost & Sullivan’s 2013 report “Smart Prevention-Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplements.”
For more infographics, visit www.supplementforsmartprevention.org
Infographic courtesy of the Council for Responsible Nutrition
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
2 Commerce Drive
Cranbury, NJ 08512